§ Mr. Carter-Jonesasked the Secretary of State for Social Services what is his estimate of the percentage of adverse reactions to Depo Provera; and on what statistical analysis his reply is given.
§ Dr. VaughanI refer the hon. Member to my reply to him on 18 July.—[Vol. 988, c.739–80.]
§ Mr. Carter-Jonesasked the Secretary of State for Social Services (1) whose responsibility it is to inform the medical profession that the use of Depo Provera in the support of pregnancy is no longer licensed;
(2) what instructions have been issued by his Department to general practioners and hospital doctors regarding the removal of the licence for Depo Provera in the support of pregnancy.
§ Dr. VaughanI refer the hon. Member to my reply to him on 2 May.—[Vol. 983, c.721–22.]
§ Mr. Carter-Jonesasked the Secretary of State for Social Services if, having regard to the findings printed in The Lancet on 5 November 1977 by Dr. Parveen et al concerning the use of Medroxyprogesterone Acetate, Depo Provera, in Bangladesh, and in view of the fact that any irregularities in the menstrual cycles of women of both Muslim and Hindu faiths can have serious effects on both their social and religious activities, he will ask the Committee on Safety of Medicines to review the advice which it gives to doctors explaining the possible adverse side effects when prescribing the drug to women of these religions.
§ Dr. VaughanI can add nothing to my reply to the hon. Member on 10 July.—[Vol. 988, c.282.]
§ Mr. Carter-Jonesasked the Secretary of State for Social Services (1) if the Committee on Safety of Medicines or his Department knows of any hospitals which have banned or discontinued the use of Depo Provera; if any reasons have been given; and if he will make a statement;
(2) if the Committee on Safety of Medicines has received any inquiries or complaints from hospital consultants regarding the adverse side effects of Depo Provera; if such complaints would be counted as yellow card complaints; if the Committee on Safety of Medicines has followed up such inquiries and complaints; and if he will make a statement.
§ Dr. VaughanI can add nothing to my reply to the hon. Member on 9 July; and to my right hon. Friend's reply to the hon. Member on 10 November.—[Vol. 988, c.199–200; Vol. 992, c. 65–66.]
§ Mr. Carter-Jonesasked the Secretary of State for Social Services how many doses of Depo Provera have been purchased by each regional health authority in the last five years for which figures are available.
§ Dr. VaughanIt is regretted that this information is not readily available.